Kolaric K - Search Results

1

The causes and consequences of Alzheimer's disease: phenome-wide evidence from Mendelian randomization.

Korologou-Linden R, Bhatta L, Brumpton BM, Howe LD, Millard LAC, Kolaric K, Ben-Shlomo Y, Williams DM, Smith GD, Anderson EL, Stergiakouli E, Davies NM. Korologou-Linden R, et al. Among authors: kolaric k. Nat Commun. 2022 Aug 11;13(1):4726. doi: 10.1038/s41467-022-32183-6. Nat Commun. 2022. PMID: 35953482 Free PMC article.

2

Focal axonal swellings and associated ultrastructural changes attenuate conduction velocity in central nervous system axons: a computer modeling study.

Kolaric KV, Thomson G, Edgar JM, Brown AM. Kolaric KV, et al. Physiol Rep. 2013 Aug;1(3):e00059. doi: 10.1002/phy2.59. Epub 2013 Aug 28. Physiol Rep. 2013. PMID: 24303138 Free PMC article.

3

Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: a randomized multinational study.

Ackland SP, Anton A, Breitbach GP, Colajori E, Tursi JM, Delfino C, Efremidis A, Ezzat A, Fittipaldo A, Kolaric K, Lopez M, Viaro D; HEPI 013 study group. Ackland SP, et al. Among authors: kolaric k. J Clin Oncol. 2001 Feb 15;19(4):943-53. doi: 10.1200/JCO.2001.19.4.943. J Clin Oncol. 2001. PMID: 11181656 Clinical Trial.

4

High doses of 5-fluorouracil and epirubicin with or without cisplatin in advanced gastric cancer: a randomized study.

Roth A, Kolaric K, Zupanc D, Oresic V, Roth A, Ebling Z. Roth A, et al. Among authors: kolaric k. Tumori. 1999 Jul-Aug;85(4):234-8. doi: 10.1177/030089169908500404. Tumori. 1999. PMID: 10587023 Clinical Trial.

5

A phase II trial of cardioprotection with Cardioxane (ICRF-187) in patients with advanced breast cancer receiving 5-fluorouracil, doxorubicin and cyclophosphamide.

Kolaric K, Bradamante V, Cervek J, Cieslinska A, Cisarz-Filipcak E, Denisov LE, Donat D, Drosik K, Gershanovic M, Hudziec P, et al. Kolaric K, et al. Oncology. 1995 May-Jun;52(3):251-5. doi: 10.1159/000227467. Oncology. 1995. PMID: 7715910 Clinical Trial.

6

Combination of 5-fluorouracil, imidazole carboxamide, BCNU and prednisolone (FIB-P) as a salvage chemotherapy in heavily pretreated breast cancer patients.

Cufer T, Kolaric K, Cervek J, Cerar O. Cufer T, et al. Among authors: kolaric k. Tumori. 1992 Feb 29;78(1):26-31. doi: 10.1177/030089169207800106. Tumori. 1992. PMID: 1609455

7

Randomized phase II trial of high-dose 4'-epi-doxorubicin + cyclophosphamide versus high-dose 4'-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung cancer.

Kánitz E, Kolaric K, Jassem J, Mechl Z, Pawlicki M, Ringwald G, Rolski J, Schoket Z, Vukas D, Kaplan E, et al. Kánitz E, et al. Among authors: kolaric k. Oncology. 1992;49(5):327-32. doi: 10.1159/000227066. Oncology. 1992. PMID: 1326734 Clinical Trial.

8

Carboplatin activity in untreated metastatic breast cancer patients--results of a phase II study.

Kolarić K, Vukas D. Kolarić K, et al. Cancer Chemother Pharmacol. 1991;27(5):409-12. doi: 10.1007/BF00688868. Cancer Chemother Pharmacol. 1991. PMID: 1999004 Clinical Trial.

9

Combination of idarubicin and cyclophosphamide administered orally in untreated postmenopausal breast cancer patients. A phase II study.

Kolarić K, Mechl Z. Kolarić K, et al. Oncology. 1991;48(2):93-6. doi: 10.1159/000226903. Oncology. 1991. PMID: 1997944 Clinical Trial.

10

cis-platinum-based alternating non-cross-resistant chemotherapy as a first-line treatment in metastatic breast cancer. A phase II study.

Kolarić K, Tomek R. Kolarić K, et al. Tumori. 1990 Oct 31;76(5):472-5. doi: 10.1177/030089169007600511. Tumori. 1990. PMID: 2256193 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page